High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples

存档胰腺腺癌样本的高清克隆分析

基本信息

  • 批准号:
    8220862
  • 负责人:
  • 金额:
    $ 23.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Genomic instability appears to cooperate with Darwinian selection to promote cancer formation through a process in which genomic aberrations occur at accelerated rates, and those alterations that provide a selective growth advantage lead to clonal evolution and expansion. Consequently the patterns of genomic aberrations in cancers can vary extensively, even in tumors arising in the same organ site. A fundamental hypothesis of current cancer genome efforts is that tumor cells become differentially resistant or sensitive to available clinical interventions according to selected aberrations present in each sample and the pathways that they target. Thus the identification of selected aberrations in patient samples will help develop novel therapeutic targets that can be advanced for improved more personalized approach to the treatment of cancer. Recent advances in genomic technologies provide highly detailed analyses of samples of interest. For example oligonucleotide CGH arrays can distinguish single copy changes across an entire genome at intragenic mapping resolution with probe error rates of <5%. A challenge in studying complex tissues is the presence of admixtures of cells and the polyclonal nature of human neoplasias. Furthermore, in addition to masking critical genomic aberrations, the presence of clonal mixtures of neoplastic cell populations in biopsies makes it prohibitively difficult to discern which genomic aberrations occur concurrently and to comprehensively define the genomic contexts of patient samples. Formalin fixed paraffin embedded (FFPE) tissues are a vast resource of clinically annotated samples with patient follow-up data including diagnostic and therapeutic outcomes. As such, these samples represent highly desirable and informative materials for the application of high definition genomics that could improve patient management and provide the molecular basis for the selection of personalized therapeutics. However a major limitation to the use of these samples for high resolution genomic analyses to date is the highly variable quality of the DNA extracted from samples of interest. Flow cytometry has been used to identify and isolate neoplastic clones from primary biopsies in a variety of tissues using objective quantifiable markers. Once identified individual populations can be flow purified to greater than 95% purity for subsequent molecular analyses. We have recently developed methods that adapt single parameter flow cytometry of fresh frozen samples to high definition clonal aCGH analyses of pancreatic cancer. The overall objective of this application is to extend these methods by developing and validating multiparameter flow cytometry assays that are compatible with high definition array CGH analyses and next generation sequencing of clinical samples. These will include diploid and aneuploid cell populations from formulin fixed paraffin embedded (FFPE) samples of pancreatic adenocarcinomas.
描述(由申请人提供):基因组不稳定性似乎与达尔文选择合作,通过基因组畸变加速发生的过程促进癌症的形成,而那些提供选择性生长优势的改变导致克隆进化和扩展。因此,癌症中基因组畸变的模式可以有很大的不同,甚至在同一器官部位产生的肿瘤中也是如此。当前癌症基因组研究的一个基本假设是,肿瘤细胞根据每个样本中存在的选择畸变及其靶向途径,对可用的临床干预产生不同的抗性或敏感性。因此,在患者样本中选定畸变的识别将有助于开发新的治疗靶点,从而改进更个性化的癌症治疗方法。基因组技术的最新进展为感兴趣的样本提供了非常详细的分析。例如,寡核苷酸CGH阵列可以在基因内定位分辨率下区分整个基因组的单拷贝变化,探针错误率<5%。研究复杂组织的一个挑战是细胞混合物的存在和人类肿瘤的多克隆性。此外,除了掩盖关键的基因组畸变外,活组织检查中肿瘤细胞群的克隆混合物的存在使得辨别哪些基因组畸变同时发生以及全面定义患者样本的基因组背景变得非常困难。福尔马林固定石蜡包埋(FFPE)组织是临床注释样本的巨大资源,患者随访数据包括诊断和治疗结果。因此,这些样本代表了高清晰度基因组学应用的高度期望和信息材料,可以改善患者管理并为个性化治疗的选择提供分子基础。然而,迄今为止,使用这些样本进行高分辨率基因组分析的一个主要限制是从感兴趣的样本中提取的DNA质量高度可变。流式细胞术已被用于识别和分离肿瘤克隆的原发活检在各种组织使用客观的可量化的标记。一旦确定的个体群体可以流动纯化到大于95%的纯度用于随后的分子分析。我们最近开发了一种方法,使新鲜冷冻样品的单参数流式细胞术适用于胰腺癌的高清晰度克隆aCGH分析。本应用程序的总体目标是通过开发和验证与高清晰度阵列CGH分析和下一代临床样品测序兼容的多参数流式细胞术分析来扩展这些方法。这些将包括来自胰脏腺癌配方固定石蜡包埋(FFPE)样本的二倍体和非整倍体细胞群。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael T Barrett其他文献

Michael T Barrett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael T Barrett', 18)}}的其他基金

Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
通过游离 DNA 中的基因沉默景观监测免疫治疗反应
  • 批准号:
    10760450
  • 财政年份:
    2023
  • 资助金额:
    $ 23.54万
  • 项目类别:
HRD-IA signatures in pancreatic ductal adenocarcinoma
胰腺导管腺癌中的 HRD-IA 特征
  • 批准号:
    10551899
  • 财政年份:
    2022
  • 资助金额:
    $ 23.54万
  • 项目类别:
New Therapuetics for Pancreatic Cancer
胰腺癌的新疗法
  • 批准号:
    10617320
  • 财政年份:
    2022
  • 资助金额:
    $ 23.54万
  • 项目类别:
HRD-IA signatures in pancreatic ductal adenocarcinoma
胰腺导管腺癌中的 HRD-IA 特征
  • 批准号:
    10515859
  • 财政年份:
    2022
  • 资助金额:
    $ 23.54万
  • 项目类别:
High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples
存档胰腺腺癌样本的高清克隆分析
  • 批准号:
    8035406
  • 财政年份:
    2010
  • 资助金额:
    $ 23.54万
  • 项目类别:
High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples
存档胰腺腺癌样本的高清克隆分析
  • 批准号:
    7778986
  • 财政年份:
    2010
  • 资助金额:
    $ 23.54万
  • 项目类别:

相似海外基金

Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10818088
  • 财政年份:
    2023
  • 资助金额:
    $ 23.54万
  • 项目类别:
Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers in African Americans
非裔美国人冠心病和相关代谢组标记物的混合图谱
  • 批准号:
    10571022
  • 财政年份:
    2023
  • 资助金额:
    $ 23.54万
  • 项目类别:
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
  • 批准号:
    10590405
  • 财政年份:
    2023
  • 资助金额:
    $ 23.54万
  • 项目类别:
NSF Postdoctoral Fellowship in Biology: Coalescent Modeling of Sex Chromosome Evolution with Gene Flow and Analysis of Sexed-versus-Gendered Effects in Human Admixture
NSF 生物学博士后奖学金:性染色体进化与基因流的合并模型以及人类混合中性别与性别效应的分析
  • 批准号:
    2305910
  • 财政年份:
    2023
  • 资助金额:
    $ 23.54万
  • 项目类别:
    Fellowship Award
Admixture mapping of mosaic copy number alterations for identification of cancer drivers
用于识别癌症驱动因素的马赛克拷贝数改变的混合图谱
  • 批准号:
    10608931
  • 财政年份:
    2022
  • 资助金额:
    $ 23.54万
  • 项目类别:
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients
利用微生物组、局部混合物和机器学习来优化医疗服务不足的患者的抗凝药物基因组学
  • 批准号:
    10656719
  • 财政年份:
    2022
  • 资助金额:
    $ 23.54万
  • 项目类别:
The role of admixture in human evolution
混合物在人类进化中的作用
  • 批准号:
    10683318
  • 财政年份:
    2022
  • 资助金额:
    $ 23.54万
  • 项目类别:
Genealogical ancestors, admixture, and population history
家谱祖先、混合和人口历史
  • 批准号:
    2116322
  • 财政年份:
    2021
  • 资助金额:
    $ 23.54万
  • 项目类别:
    Standard Grant
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10307040
  • 财政年份:
    2021
  • 资助金额:
    $ 23.54万
  • 项目类别:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
非裔美国儿童急性淋巴细胞白血病的混合分析:ADMIRAL 研究
  • 批准号:
    10307680
  • 财政年份:
    2021
  • 资助金额:
    $ 23.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了